These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8005855

  • 21. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM, Cuevas JM, Ignarro LJ, Chaudhuri G.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [Abstract] [Full Text] [Related]

  • 22. Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice.
    Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH.
    Korean J Intern Med; 1996 Jun; 11(2):93-100. PubMed ID: 8854644
    [Abstract] [Full Text] [Related]

  • 23. A central nervous system action of nitric oxide in blood pressure regulation.
    Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):343-7. PubMed ID: 1378094
    [Abstract] [Full Text] [Related]

  • 24. Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes.
    Oddis CV, Simmons RL, Hattler BG, Finkel MS.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):992-7. PubMed ID: 7528506
    [Abstract] [Full Text] [Related]

  • 25. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K, Klatt P, Mayer B.
    Mol Pharmacol; 1993 Sep 15; 44(3):615-21. PubMed ID: 7690451
    [Abstract] [Full Text] [Related]

  • 26. Nitric oxide modulates lymphocyte proliferation but not secretion of IL-2.
    Huot AE, Moore AL, Roberts JD, Hacker MP.
    Immunol Invest; 1993 Jun 15; 22(4):319-27. PubMed ID: 7689536
    [Abstract] [Full Text] [Related]

  • 27. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs.
    Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K.
    J Neurosurg; 1994 Mar 15; 80(3):476-83. PubMed ID: 8113861
    [Abstract] [Full Text] [Related]

  • 28. The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
    Egi Y, Matsumura Y, Murata S, Umekawa T, Hisaki K, Takaoka M, Morimoto S.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):529-35. PubMed ID: 7514219
    [Abstract] [Full Text] [Related]

  • 29. The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion.
    Mueller AR, Platz KP, Langrehr JM, Hoffman RA, Nussler AK, Nalesnik M, Billiar TR, Schraut WH.
    Transplantation; 1994 Dec 27; 58(12):1309-16. PubMed ID: 7809922
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine.
    Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL.
    J Immunol; 1990 Oct 01; 145(7):2220-6. PubMed ID: 2144548
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2.
    Blanco FJ, Lotz M.
    Exp Cell Res; 1995 May 01; 218(1):319-25. PubMed ID: 7537695
    [Abstract] [Full Text] [Related]

  • 34. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ, Modzelewski RA, Russell DM, Johnson CS.
    Cancer Res; 1996 Feb 15; 56(4):886-91. PubMed ID: 8631029
    [Abstract] [Full Text] [Related]

  • 35. Expression and functional role of nitric oxide synthase in osteoblast-like cells.
    Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernández-Luna JL, González-Macías J.
    J Bone Miner Res; 1995 Mar 15; 10(3):439-46. PubMed ID: 7540349
    [Abstract] [Full Text] [Related]

  • 36. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
    Samlowski WE, Kondapaneni M, Tharkar S, McGregor JR, Laubach VE, Salvemini D.
    J Immunother; 2011 Jun 15; 34(5):419-27. PubMed ID: 21577143
    [Abstract] [Full Text] [Related]

  • 37. The effects of nitric oxide on chondrocytes and lymphocytes.
    Kondo S, Ishiguro N, Iwata H, Nakashima I, Isobe K.
    Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1431-7. PubMed ID: 8280161
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
    Naess PA, Kirkebøen KA, Christensen G, Kiil F.
    Am J Physiol; 1992 Jun 30; 262(6 Pt 2):F939-42. PubMed ID: 1535755
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
    Studer RK, Georgescu HI, Miller LA, Evans CH.
    Arthritis Rheum; 1999 Feb 30; 42(2):248-57. PubMed ID: 10025918
    [Abstract] [Full Text] [Related]

  • 40. Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent.
    Juretic A, Spagnoli GC, von Bremen K, Hörig H, Filgueira L, Lüscher U, Babst R, Harder F, Heberer M.
    Cell Immunol; 1994 Sep 30; 157(2):462-77. PubMed ID: 8069927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.